← Leaderboards
Albert Craig Lockhart
Vanderbilt University
$3,804,812
Attributed
$8,130,950
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,130,950 · 9
By mechanism
UG1$4,774,115 · 1
K12$1,012,554 · 1
UM1$707,333 · 1
K23$620,190 · 1
R21$549,512 · 1
P50$463,348 · 1
Top collaborators
- Marvella Elizabeth Ford5 shared
- David T. Marshall5 shared
- Elizabeth C Dees2 shared
- Evan Michael Graboyes2 shared
- Herbert I Hurwitz2 shared
- John M. Wrangle2 shared
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelCancer CenterMalignant NeoplasmsClinical ResearchProgramsUniversitiesCancer PatientImageEnrollmentMedicalBaseClinical TrialsInstitutionRecruitPreventionFutureCancer ControlTranslational ResearchAnticancer ResearchCancer PreventionFundingPatient PopulationAftercareOncology
Grant awards (25)
Medical University of South Carolina NCORP Community Site$1,038,731
UG1 · FY2025 · CA
Medical University of South Carolina NCORP Minority/Underserved Community Site$948,023
UG1 · FY2024 · CA
Medical University of South Carolina NCORP Minority/Underserved Community Site$993,808
UG1 · FY2023 · CA
Medical University of South Carolina NCORP Minority/Underserved Community Site$970,975
UG1 · FY2022 · CA
MUSC/HCC Paul Calabresi Clinical Oncology Career Development Program$396,181
K12 · FY2022 · CA
Medical University of South Carolina NCORP Minority/Underserved Community Site$822,578
UG1 · FY2021 · CA
MUSC/HCC Paul Calabresi Clinical Oncology Career Development Program$616,373
K12 · FY2021 · CA
Developmental Research Program$103,135
P50 · FY2020 · CA · contact PI
Developmental Research Program$96,559
P50 · FY2019 · CA · contact PI
Developmental Research Program$103,718
P50 · FY2018 · CA · contact PI
Developmental Research Program$84,023
P50 · FY2017 · CA · contact PI
Developmental Research Program$75,913
P50 · FY2016 · CA · contact PI
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer$201,163
UM1 · FY2015 · CA
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer$506,170
UM1 · FY2014 · CA
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction$264,256
R21 · FY2008 · CA · contact PI
Genetic Polymorphisms Affecting Chemotherapy Disposition$122,585
K23 · FY2008 · CA · contact PI
Genetic Polymorphisms Affecting Chemotherapy Disposition$1,453
K23 · FY2008 · CA · contact PI
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction$285,256
R21 · FY2007 · CA · contact PI
Genetic Polymorphisms Affecting Chemotherapy Disposition$124,038
K23 · FY2007 · CA · contact PI
Genetic Polymorphisms Affecting Chemotherapy Disposition$124,038
K23 · FY2006 · CA · contact PI
CORRELATION ON THE PHARMACOKINETICS AND TOXICITY OF CPT-11 WITH FUNCTIONALLY$1,258
M01 · FY2006 · RR · contact PI
RESPONSE TO PACLITAXEL RELATED TO GENITIC VARIATINS IN MDR1$1,258
M01 · FY2006 · RR · contact PI
Genetic Polymorphisms Affecting Chemotherapy Disposition$124,038
K23 · FY2005 · CA
CORRELATION ON THE PHARMACOKINETICS AND TOXICITY OF CPT-11 WITH FUNCTIONALLY$1,382
M01 · FY2005 · RR
Genetic Polymorphisms Affecting Chemotherapy Disposition$124,038
K23 · FY2004 · CA